Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period   By considering a definite base year...

The global genetic testing services market is experiencing remarkable growth due to the increasing adoption of precision medicine, rising awareness regarding hereditary diseases, and rapid advancements in genomic technologies. Genetic testing services are becoming essential across healthcare systems for disease diagnosis, risk assessment, treatment planning, and preventive healthcare...

The Global Nucleic Acid Isolation and Purification Market is poised for strong expansion, projected to grow at a CAGR of 8.5% and reach USD 8.87 billion by 2030. As molecular biology, genomics, and precision medicine continue to evolve at a rapid pace, the demand for high-quality nucleic acid extraction solutions is surging across research, diagnostics, and...

Molecular Point of Care Testing Market Overview The molecular point of care testing (POCT) market is a rapidly evolving segment of the global diagnostics and healthcare technology industry. Molecular POCT refers to diagnostic testing performed at or near the site of patient care using nucleic acid amplification tests (NAAT) to detect genetic material from pathogens. These tests...

The global Sanger sequencing service market is experiencing robust growth due to the increasing demand for accurate DNA sequencing technologies in clinical diagnostics, pharmaceutical research, biotechnology, and academic studies. Sanger sequencing remains one of the most reliable methods for validating genetic variations, mutation detection, and targeted sequencing applications. The Sanger...

U.S. Solid Tumor Testing Market Advances as Thermo Fisher Scientific Expands Precision Oncology, with Global Market Rising from USD 32.9 billion in 2026 to USD 65.9 billion by 2036 at a 7.2% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The global solid tumor testing market reached a valuation of USD 30.7 billion in 2025. Demand is projected to expand from USD...